Equities

GemPharmatech Co Ltd

688046:SHH

GemPharmatech Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)10.74
  • Today's Change0.10 / 0.94%
  • Shares traded2.80m
  • 1 Year change-45.01%
  • Beta--
Data delayed at least 15 minutes, as of Jul 30 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

GemPharmatech Co Ltd, formerly Jiangsu Jicui Yaokang Biotechnology Co Ltd, is a China-based company principally engaged in the research, development, production and sales of experimental mouse models. The Company uses gene-editing and other technologies to produce mouse models. The Company also involves in the business of customized model breeding, drug efficacy analysis, and model customization. The Company’s products are mainly used to satisfy the experimental demands in the fields of gene function cognition, disease mechanisms analysis, drug target discovery, and other fundamental researches.

  • Revenue in CNY (TTM)638.97m
  • Net income in CNY157.34m
  • Incorporated2017
  • Employees1.51k
  • Location
    GemPharmatech Co LtdNo. 12 Xuefu Road, Jiangbei New AreaNANJING 210061ChinaCHN
  • Phone+86 2 558265927
  • Fax+86 2 558265927
  • Websitehttps://www.gempharmatech.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Hinova Pharmaceuticals Inc0.00-266.00m2.39bn179.00--1.80-----2.69-2.690.0013.390.00105.68--0.00-17.03-31.86-18.39-37.18-------25,578.2411.83--0.0097---100.00--2.44--124.37--
Shanghai Aladdin Biochemical Tech Co Ltd414.81m85.68m2.60bn566.0025.992.46--6.260.36020.36021.383.800.28030.38989.21732,874.105.798.836.209.6160.0861.4920.6626.858.00--0.251945.716.5519.36-7.489.9531.41--
Bide Pharmatech Co Ltd1.10bn98.72m2.63bn846.0026.591.28--2.381.091.0912.1422.500.45851.094.761,302,686.004.06--4.62--38.38--8.86--5.29--0.0416--30.94---24.94------
Jiangsu Yahong Meditech Co Ltd38.05m-420.35m2.81bn394.00--1.22--73.85-0.7375-0.73750.06684.030.01423.053.7696,573.63-15.68-15.80-16.54-16.4877.7255.32-1,106.10-9,445.9111.34--0.0684--52,594.79---62.42--64.28--
Qingdao Vland Biotech INC1.25bn82.87m3.02bn1.57k35.931.76--2.410.33260.33265.026.810.44313.424.33797,663.403.805.785.777.8945.3846.138.5810.340.8387149.270.289633.593.078.0515.56-0.650724.68-6.89
Shanghai Medicilon Inc1.17bn-172.33m3.80bn2.60k--1.54--3.23-1.24-1.249.1118.340.42056.631.64451,437.20-6.179.34-7.9711.7312.4836.71-14.6814.932.63--0.122920.18-17.6833.26-109.82--23.60--
Beijing Kawin Technol Sha-hld Co Ltd1.43bn117.53m3.86bn584.0031.952.13--2.690.70610.70618.6110.600.62641.664.422,451,945.006.115.317.696.7682.3586.029.768.103.25--0.080943.8221.7314.8739.7121.0425.01--
HitGen Inc409.13m64.05m3.87bn452.0060.332.81--9.460.16010.16011.023.440.2416.704.84905,165.503.774.634.025.1051.4658.8915.6620.6614.48360.770.14219.1412.6419.6961.16-1.96-6.12--
InventisBio Co Ltd194.13m-249.28m4.09bn221.00--2.11--21.06-0.4289-0.42890.33483.350.0898--1.96878,429.50-11.53---12.26--97.85---128.41------0.0054------41.26------
Beijing Sun-Novo Pharma Research Co Ltd951.95m209.57m4.11bn1.37k19.604.05--4.321.871.878.509.060.546526.191.77694,854.3011.7012.9919.1321.7059.1053.9321.4021.341.7745.000.372110.7437.7647.2218.0854.9034.77--
GemPharmatech Co Ltd638.97m157.34m4.36bn1.51k27.722.05--6.830.38380.38381.565.200.26174.112.36424,282.406.449.457.2811.1366.4370.2124.6228.164.68--0.059214.6820.4563.48-3.48--141.38--
Data as of Jul 30 2024. Currency figures normalised to GemPharmatech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

23.23%Per cent of shares held by top holders
HolderShares% Held
Zhong Ou Asset Management Co., Ltdas of 31 Dec 202311.76m7.92%
Caitong Fund Management Co., Ltd.as of 31 Dec 202311.27m7.59%
China Universal Asset Management Co., Ltd.as of 31 Dec 20233.18m2.14%
GF Fund Management Co., Ltd.as of 31 Dec 20231.76m1.19%
China Southern Asset Management Co., Ltd.as of 31 Dec 20231.52m1.03%
Lion Fund Management Co., Ltd.as of 31 Dec 20231.08m0.73%
Changsheng Fund Management Co., Ltd.as of 31 Dec 20231.05m0.71%
Ping An Fund Management Co., Ltd.as of 31 Dec 20231.03m0.70%
Great Wall Fund Management Co., Ltd.as of 31 Dec 2023943.98k0.64%
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023872.72k0.59%
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.